|Day Low/High||173.80 / 179.15|
|52 Wk Low/High||172.62 / 398.88|
A break of the stock's 2018 lows would mean that the $100 area from late 2016 is the next downside price target.
The non-consumer economy is just plain worrisome, says Jim Cramer, and our industrials are warning of weakness related to the trade war with China.
GOOGL cruised past the estimates and management provided enough disclosures around Google Cloud and what's driving YouTube to keep investors happy.
We can only hope that Fed Chairman Jay Powell is checking in with power companies and other industrials to see how tariffs are really decking parts of this country.
Here's the only way to explain why stocks jump like mad if the companies underneath them only perform slightly better than the analysts worried they would.
The Invisalign maker sinks on downgrades and price-target cuts after the company lowered guidance and warned of soft China sales.
After Facebook posted a great report yet saw its shares decline in morning trading Thursday, investors may be nervous about how Amazon, Alphabet and others fare after releasing their results.
Semiconductor strength and Mario Draghi's dovishness could be catalysts that help build on momentum.
Achieves 7 Millionth Invisalign Patient Milestone
In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Align Technology Inc has taken over the #35 spot from Masco Corp. , according to ETF Channel.
Jim Cramer says save the bubble-talk for the bathtub. The money investors can make in the market is real, and due to ingenuity, competitiveness and economic growth.
3D printing ultimately will drive the made-to-order market of the future. Although there's few pure plays, one company is already using the technology to profit.
Align Technology shares fall after the medical device maker said talks with Straumann Group over a possible development and distribution deal had ended.
Jim Cramer says it's the start CNBC's annual Stock Draft Contest, but he cautions Mad Money viewers that although investing can be fun, it requires discipline and doing your homework.
Align Technology revenue expected to rise 21.6% to $531.2 million.
Jim Cramer says days like this are reminders of how important short-selling can be to an up market.
Jim Cramer weighs in on Canopy Growth, Baidu.com, CarGurus, IAMGOLD, Align Technology, Johnson & Johnson, Electronic Arts and more.
No indicators to support giddiness as breadth improves, small caps join the party, and number of new highs looks pretty small.
In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Align Technology Inc has taken over the #36 spot from WellCare Health Plans Inc , according to ETF Channel. Below is a chart of Align Technology Inc versus WellCare Health Plans Inc plotting their respective rank within the S&P 500 over time (ALGN plotted in blue; WCG plotted in green): In forming the rank, the analyst opinions from the major brokerage houses were tallied, and averaged; then, the underlying components were ranked according to those averages.
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Align Technology Inc , where a total volume of 11,352 contracts has been traded thus far today, a contract volume which is representative of approximately 1.1 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 90.4% of ALGN's average daily trading volume over the past month, of 1.3 million shares.
Requires Align Technology Inc. To Close Down All of Its 12 Invisalign Stores and Prohibits Any New Store Openings
Align Technology loses an arbitration case against SDC Entities and will now have to close Invisalign stores.
The bottom line on sentiment is I believe we’ve seen a shift but we are nowhere near an extreme.
Jim Cramer looks at the recent action in Apple and a few other tech winners, and says everyone who dumped them now has seller's remorse.
Apple shares are up nearly 4% in after-hours trading.
In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Align Technology Inc has taken over the #40 spot from Nektar Therapeutics , according to ETF Channel. Below is a chart of Align Technology Inc versus Nektar Therapeutics plotting their respective rank within the S&P 500 over time (ALGN plotted in blue; NKTR plotted in green): In forming the rank, the analyst opinions from the major brokerage houses were tallied, and averaged; then, the underlying components were ranked according to those averages.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.